[PDF] Top 20 Una nueva especie del género Salvia sección Membranaceae de Guerrero, México
Has 10000 "Una nueva especie del género Salvia sección Membranaceae de Guerrero, México" found on our website. Below are the top 20 most common "Una nueva especie del género Salvia sección Membranaceae de Guerrero, México".
Immunotherapy in the management of melanoma: current status
... with current therapy are ...metastatic melanoma may not be as concerning as the quality of that time period and the absence of underlying side effects (see Table ...with melanoma, those who ... See full document
5
Current status of granulocyte–macrophage colony-stimulating factor in the immunotherapy of melanoma
... In a phase 1 study, patients with subcutaneous or cu- taneous metastases from breast, gastrointestinal, head and neck, or melanoma malignancies were treated with T-VEC. Clinically stable disease was noted in 3/26 ... See full document
29
Immunotherapy for hepatocellular carcinoma: current status and future perspectives
... malignant melanoma, the expression of PD-L1 in tumour tissue and the expression of tumour-in- filtrating lymphocytes are reportedly associated with the efficacy of this ... See full document
12
The use of immunotherapy in the treatment of melanoma
... metastatic melanoma correlates with the presence of tumor-infiltrating lymphocytes (TILs) in human mela- nocytic lesions, such that 98% of PD-L1(+) tumors were associated with TILs compared with only 28% of ... See full document
7
Advances in immunotherapy for melanoma
... despite management with immu- nomodulatory ...III melanoma, it is as yet unclear whether the reduction in re- currence rate with ipilimumab represents an improvement over adjuvant IFN therapy and whether ... See full document
47
New developments in the management of advanced melanoma – role of pembrolizumab
... the immunotherapy approach was improved by the introduction of ipilimumab, which is a fully human IgG1 monoclonal antibody eliciting antitumor T-cell-mediated response by interference with cytotoxic T-lymphocyte ... See full document
16
Melanoma and immunotherapy bridge 2015
... IIB-C/III/IV melanoma that surgically resectable carry a high risk for melanoma recurrence and death from melanoma with surgical management ...targets melanoma micrometastases and is ... See full document
12
Osteosarcoma: Current status of immunotherapy and future trends (Review)
... from melanoma and resulted in major clinical responses ...antigens: melanoma- associated antigen (MAGE) (6), squamous cell carcinoma antigen recognized by T cells (SART) 1 (7), SART3 (8) and papillomavirus ... See full document
22
Current perspectives on the role of telemedicine in the management of Parkinson’s disease
... On the basis of the strengths and weaknesses of telemedi- cine we have outlined, it is possible to describe some of the qualities of an ideal telemedicine program. Many of the technological difficulties reported in the ... See full document
9
Combination immune checkpoint inhibitor therapy nivolumab and ipilimumab associated with multiple endocrinopathies
... Immune checkpoint inhibitor therapy has outperformed targeted molecular therapies in the treatment of advanced melanoma. Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) is a protein receptor expressed on ... See full document
96
Ipilimumab in the treatment of metastatic melanoma: management of adverse events
... The most frequent GI side effect is diarrhea, characterized by watery/bloody stools, reported with a frequency of 20%–31% in the ipilimumab groups of the MDX010-20 Phase III trial, which led in 2011 to US Food and Drug ... See full document
15
New emerging targets in cancer immunotherapy: the role of TIM3
... The only data currently available are a preliminary anal- ysis from the phase I Amber trial. It includes an anti-TIM3 Ab, TSR-022, alone and in combination with an anti- PD-1 Ab. At the time of analysis, data were ... See full document
74
Association of Gender with Efficacy of Immunotherapy in Metastatic Melanoma
... of immunotherapy between males and females (OR: ...receiving immunotherapy included treatment at academic centers, presence of extra- cranial metastatic disease (liver, lung or bone), and a later year of ... See full document
37
Current and planned activities in the field of water management in Serbia
... wastewater management and improvement of drinking water ...Water Management in the Republic of Serbia” that will establish a long-term direction for water ...water management plans. Several water ... See full document
6
Tumor control with PD-1 inhibition in a patient with concurrent metastatic melanoma and renal cell carcinoma
... of melanoma, PD-1 pathway inhibition is efficacious against a wide spectrum of solid and hematological malignancies includ- ing RCC, non-small cell lung cancer, bladder cancer, and Hodgkin’s ...in current ... See full document
36
<p>Sentinel lymph node biopsy in the management of conjunctival melanoma: current insights</p>
... cutaneous melanoma, initial metas- tasis predominantly, though not exclusively, occurs to the regional lymph nodes (as opposed to uveal melanomas which typically initially metastasize to the liver) and can be ... See full document
5
Current Status of the Etiology and Management of Dysmenorrhea in Adolescence
... Pulkkinen MO, Csapo A!: Effect of ibuprofen on menstrual blood prostaglandin levels in dysmenorrheic women. Martin JN Jr, Bygdeman M: The effect of locally admin- istered PGE on the cont[r] ... See full document
10
Current Status of the Identification and Management of Tinea Capitis
... More limited form of T tonsurans tinea capitis in 6-year-old male sibling of patient in Fig 1. Fig 3[r] ... See full document
31
Lantana: current management status and future prospects.
... Their usefulness as a biocontrol agent in Australia at least has been questioned, as there are already a large number of indigenous and introduced mite species that attack lantana, witho[r] ... See full document
24
<p>Current status of liquid biopsies for the detection and management of prostate cancer</p>
... Liquid biopsy is a fast-evolving fi eld with the potential to change patient management across a broad spectrum of cancer types, including PC. Until now, CTC enumerated by CellSearch has been by far the best ... See full document
73
Related subjects